AcouSort AB (ACOU) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AcouSort AB (ACOU) has a cash flow conversion efficiency ratio of 0.627x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr8.61 Million ≈ $926.25K USD) by net assets (Skr13.74 Million ≈ $1.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ACOU market cap overview for the company's overall valuation and market capitalisation.
AcouSort AB - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how AcouSort AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
AcouSort AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AcouSort AB ranked by their cash flow conversion efficiency. Explore ACOU cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Corella Resources Ltd
AU:CR9
|
-0.129x |
|
IL&FS Transportation Networks Limited
NSE:IL&FSTRANS
|
0.000x |
|
TNF Pharmaceuticals, Inc.
NASDAQ:TNFA
|
-0.178x |
|
DGB Group NV
AS:DGB
|
0.235x |
|
Micro Digital Co. Ltd
KQ:305090
|
-0.143x |
|
PLAYWITH Inc
KQ:023770
|
-0.027x |
|
ECS Botanics Holdings Ltd
AU:ECS
|
0.015x |
|
Openn Negotiation Ltd
AU:OPN
|
0.905x |
Annual Cash Flow Conversion Efficiency for AcouSort AB (2013–2025)
The table below shows the annual cash flow conversion efficiency of AcouSort AB from 2013 to 2025. View AcouSort AB share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr16.30 Million ≈ $1.75 Million |
Skr-16.78 Million ≈ $-1.81 Million |
-1.029x | +53.68% |
| 2024-12-31 | Skr8.46 Million ≈ $910.75K |
Skr-18.81 Million ≈ $-2.02 Million |
-2.222x | -69.95% |
| 2023-12-31 | Skr24.14 Million ≈ $2.60 Million |
Skr-31.56 Million ≈ $-3.40 Million |
-1.308x | -763.33% |
| 2022-12-31 | Skr20.11 Million ≈ $2.16 Million |
Skr3.96 Million ≈ $426.70K |
0.197x | +159.62% |
| 2021-12-31 | Skr33.02 Million ≈ $3.55 Million |
Skr-10.92 Million ≈ $-1.17 Million |
-0.331x | +54.92% |
| 2020-12-31 | Skr9.59 Million ≈ $1.03 Million |
Skr-7.04 Million ≈ $-757.08K |
-0.733x | +55.87% |
| 2019-12-31 | Skr5.92 Million ≈ $637.30K |
Skr-9.84 Million ≈ $-1.06 Million |
-1.662x | -250.06% |
| 2018-12-31 | Skr15.58 Million ≈ $1.68 Million |
Skr-7.40 Million ≈ $-796.04K |
-0.475x | +78.37% |
| 2017-12-31 | Skr3.88 Million ≈ $417.87K |
Skr-8.53 Million ≈ $-917.43K |
-2.195x | -10113.03% |
| 2016-12-31 | Skr9.96 Million ≈ $1.07 Million |
Skr-214.00K ≈ $-23.03K |
-0.021x | +99.78% |
| 2015-12-31 | Skr78.63K ≈ $8.46K |
Skr-757.00K ≈ $-81.47K |
-9.627x | +57.84% |
| 2014-12-31 | Skr376.48K ≈ $40.52K |
Skr-8.60 Million ≈ $-925.17K |
-22.835x | -89.13% |
| 2013-12-31 | Skr249.47K ≈ $26.85K |
Skr-3.01 Million ≈ $-324.14K |
-12.074x | -- |
About AcouSort AB
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acous… Read more